highly significantp < 0.001
The administration of ONA was associated with highly significant increases in CSP end latency (CSPe), from 118.5 ± 9.1 ms to 130.7 ± 6.2 ms ( p < 0.001), CSP duration (CSPd), from 39.6 ± 5.9 ms to 50.9 ± 7.3 ms ( p < 0.001).